NCT06957574

Brief Summary

Management of postoperative pain relief is largely inadequate. Despite the recent advances in pain management, postoperative pain incidence has not decreased; most patients still experience severe pain after major surgery. Poorly or inadequately controlled pain was reported to be linked to prolonged hospitalization, decreased patient satisfaction, the risk of readmission, and a higher incidence of postoperative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable colorectal-cancer

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

April 26, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
Last Updated

May 13, 2025

Status Verified

April 1, 2025

Enrollment Period

3.3 years

First QC Date

April 26, 2025

Last Update Submit

May 7, 2025

Conditions

Keywords

erector spinae planecolectomy

Outcome Measures

Primary Outcomes (1)

  • morphine consumption

    postoperative total morphine consumption over 24 hours

    From the time of end of surgery till the pass of the first 24 hours postoperatively

Study Arms (2)

ESPB

ACTIVE COMPARATOR

ESPB using local anaesthetic 20 ml 0.25% bupivacaine on each side

Drug: Bubpivacaine

Saline

PLACEBO COMPARATOR

ESPB using normal saline 20 ml on each side

Drug: Normal Saline (Placebo)

Interventions

ESPB using local anesthetic 20 ml 0.25% bupivacaine on each side

ESPB

ESPB using normal saline 20 ml 0.25% bupivacaine on each side

Saline

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients of colorectal carcinoma scheduled for elective colectomy

You may not qualify if:

  • Patients with a body mass index (BMI) of 35 kg/m2 or above
  • patients with a history of hepatic or renal diseases
  • patients with second- or third-degree heart blocks
  • patients with coagulopathies
  • patients with history of hypersensitivity to local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

faculty of medicine, Suez Canal University

Ismailia, Egypt

Location

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Saline Solution

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 26, 2025

First Posted

May 4, 2025

Study Start

August 1, 2021

Primary Completion

November 30, 2024

Study Completion

December 15, 2024

Last Updated

May 13, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations